Decreased expression of microRNA-375 in nonsmall cell lung cancer and its clinical significance

Journal of International Medical Research

Volumn 40, Issue 5, 2012, Pages 1662-1669

  Li, Y ^a   Jiang, Q ^a   Xia, N ^a   Yang, H ^a   Hu, Chengping ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Metastasis; MiR 375 expression; Nonsmall cell lung cancer; Prognosis; Tumour stage

Indexed keywords

MICRORNA 375; MICRORNA; MIRN375 MICRORNA, HUMAN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL LUNG CARCINOMA; TUMOR VOLUME; GENETICS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; DOWN-REGULATION; FEMALE; GENE EXPRESSION; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84880142343     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006051204000505     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
2. Miller YE: Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol 2005; 33: 216-223.
3. van der Drift MA, Hol BE, Klaassen CH, et al: Circulating DNA is a non-invasive prognostic factor for survival in non-small cell lung cancer. Lung Cancer 2010; 68: 283-287.
4. Esquela-Kerscher A, Slack FJ: Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
5. Ladeiro Y, Couchy G, Balabaud C, et al: MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 2008; 47: 1955-1963.
6. Huang Y, Shen XJ, Zou Q, et al: Biological functions of microRNAs. Bioorg Khim 2010; 36: 747-752.
7. Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004; 101: 2999-3004.
8. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714.
9. Meng F, Henson R, Wehbe-Janek H, et al: The MicroRNA let-7a modulates interleukin-6- dependent STAT-3 survival signaling in malignant human cholangiocytes. J Biol Chem 2007; 282: 8256-8264.
10. Lu L, Katsaros D, de la Longrais IA, et al: Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulinlike growth factor-II expression and favorable prognosis. Cancer Res 2007; 67: 10117-10122.
11. Chan SH, Wu CW, Li AF, et al: miR-21 microRNA expression in human gastric carcinomas and its clinical association. Anticancer Res 2008; 28: 907-911.
12. Roldo C, Missiaglia E, Hagan JP, et al: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006; 24: 4677-4684.
13. Slaby O, Svoboda M, Fabian P, et al: Altered expression of miR-21, miR-31, miR-143 and miR-145 is related to clinicopathologic features of colorectal cancer. Oncology (Williston Park) 2007; 72: 397-402.
14. Iorio MV, Ferracin M, Liu CG, et al: MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005; 65: 7065-7070.
15. Iorio MV, Visone R, Di Leva G, et al: MicroRNA signatures in human ovarian cancer. Cancer Res 2007; 67: 8699-8707.
16. Meng F, Henson R, Lang M, et al: Involvement of human micro-RNA in growth and response to chemotherapy in human cholangio - carcinoma cell lines. Gastroenterology 2006; 130: 2113-2129.
17. Meng F, Henson R, Wehbe-Janek H, et al: MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007; 133: 647-658.
18. Yanaihara N, Caplen N, Bowman E, et al: Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006; 9: 189-198.
19. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 2004; 64: 3753-3756.
20. Poy MN, Eliasson L, Krutzfeldt J, et al: A pancreatic islet-specific microRNA regulates insulin secretion. Nature 2004; 432: 226-230.
21. Mazar J, DeBlasio D, Govindarajan SS, et al: Epigenetic regulation of microRNA-375 and its role in melanoma development in humans. FEBS Lett 2011; 585: 2467-2476.
22. Avissar M, Christensen BC, Kelsey KT, et al: MicroRNA expression ratio is predictive of head and neck squamous cell carcinoma. Clin Cancer Res 2009; 15: 2850-2855.
23. Basu A, Alder H, Khiyami A, et al: MicroRNA- 375 and microRNA-221: potential noncoding RNAs associated with antiproliferative activity of benzyl isothiocyanate in pancreatic cancer. Genes Cancer 2011; 2: 108-119.
24. Li X, Lin R, Li J: Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig Dis Sci 2011; 56: 2849-2856.
25. Ding L, Xu Y, Zhang W, et al: MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res 2010; 20: 784-793.
26. He XX, Chang Y, Meng FY, et al: MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo. Oncogene 2012; 31: 3357-3369.
27. Brase JC, Johannes M, Schlomm T, et al: Circulating miRNAs are correlated with tumor progression in prostate cancer. Int J Cancer 2011; 128: 608-616.
28. Sørensen JB, Klee M, Palshof T, et al: Performance status assessment in cancer patients. An inter-observer variability study. Br J Cancer 1993; 67: 773-775.
29. Sobin LH, Wittekind C, International Union against Cancer. TNM: Classification of Malignant Tumours (6th edn). Wiley-Liss: New York, 2002; xxiii, p239.
30. Lawrie CH, Gal S, Dunlop HM, et al: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-675.
31. Lu J, Getz G, Miska EA, et al: MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
32. Cho WC: OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 2007; 6: 60.
33. Hayashita Y, Osada H, Tatematsu Y, et al: A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res 2005; 65: 9628-9632.
34. Yu SL, Chen HY, Chang GC, et al: MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008; 13: 48-57.
35. Hu G, Wei Y, Kang Y: The multifaceted role of MTDH/AEG-1 in cancer progression. Clin Cancer Res 2009; 15: 5615-5620.
36. Lee SG, Jeon HY, Su ZZ, et al: Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 2009; 28: 2476-2484.
37. Beattie J, Allan GJ, Lochrie JD, et al: Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis. Biochem J 2006; 395: 1-19.
38. Tanase CP: Caveolin-1: a marker for pancreatic cancer diagnosis. Expert Rev Mol Diagn 2008; 8: 395-404.
39. Bartel DP, Chen CZ: Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs. Nat Rev Genet 2004; 5: 396-400.
40. Krek A, Grun D, Poy MN, et al: Combinatorial microRNA target predictions. Nat Genet 2005; 37: 495-500.